General diagnostic ultrasound across abdominal, small parts, musculoskeletal, obstetric, gynaecological and vascular work is the core of what this console delivers. All clinical judgement, including whether an examination or a contrast study is indicated, which patients it suits and how findings are interpreted, remains with the referring and reporting clinicians, and Medigear.uk supplies configuration and condition detail rather than clinical guidance.
Lesion characterisation is where contrast capability contributes, allowing uptake and washout to be observed where an unenhanced study leaves a finding indeterminate.
Hepatic work is the application most commonly associated with the technique, given how frequently liver lesions are found incidentally and require characterisation rather than detection.
Patients for whom other contrast agents are avoided are the group the capability most obviously serves, with the clinical decision on suitability resting entirely with the treating team.
Follow-up imaging benefits where a lesion is being observed over time and repeated cross-sectional studies would otherwise be required.
Services should confirm the licence, the contrast-capable transducer and the software version together, since the examination requires all three and the absence of any one prevents it.